A Phase II, Multi-centre, Open Label, Randomized Study of Ribavirin and Hedgehog Inhibitor With or Without Decitabine in Acute Myeloid Leukemia (AML)
This is a research study of ribavirin which will be given in combination with vismodegib
and/or decitabine. The purpose of this study is to see if patients respond to treatment when
ribavirin is given with vismodegib alone or in combination with decitabine.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society